Project Partners

UniSR Università Vita-Salute San Raffaele

Vita-Salute San Raffaele University (UniSR) is one of the top-ranking Universities in Italy for research and teaching, with more than 200 tenured teaching staff and around 5400 registered students. UniSR is affiliated to the IRCCS Ospedale San Raffaele (OSR), which is part of the largest private hospital group in Italy. UniSR-OSR campus (Milan) is today the main Italian Research Institute in terms of volume and quality of scientific output. There researchers have the unique opportunity to transfer research straight into healthcare practice and patient’s bedside. The excellence of UniSR academic staff and the close partnership between teaching, clinical work and research allows the Faculty of Medicine to provide state-of-the-art training. 

Within the TETRIS Project, he is WP Leader and his team includes Marco Fois, Alfonso Belardo, Gabriele Palazzo and Maria Giulia Ubeira Gabellini from the Medical Physics Dept. of IRCCS San Raffaele Scientific Institute and UniSR, and Andrei Fodor from the IRCCS San Raffaele Scientific Institute Radiotherapy. 

UniSR is WP Leader of WP3 – Imaging focuses on extracting quantitative CT image-based biomarkers to be included in the risk scores developed in WP2 and into the CE-marked software tool (WP6). These biomarkers are also considered in prototyping digital twins (WP7). 

WP3 establishes all procedures needed to extract imaging biomarkers from both historical datasets (WP1) and new prospectively collected cohorts (WP9), using DICOM-RT CT images. 

The work package first evaluates inter-cohort, inter-scanner, and segmentation variability, generating harmonised auto-segmented organ contours to support consistent biomarker extraction. High-priority features, such as cardiac calcium scores, lung density, and breast density, are processed according to IBSI standards (https://theibsi.github.io/ ) and exported to the centralised database for risk modelling (WP2) and digital-twin development (WP7). Lower-priority features related to vascular calcifications, cardiac devices, and body composition are also explored for their potential predictive value. 

UniSR is also part of WP1 – Coordination and Project ManagementWP2 – Long-term Side Effects Modelling, WP3 – Imaging, WP4 – Genetics, WP5 – Transcriptomics, WP6 – Software Tool, WP7 – Digital Twins and WP8 – Cellular Sensitivity, WP9 – Prospective collection and WP10 – Dissemination and Exploitation.    

Follow Us

@projectetris
🧩 Inside the TETRIS Consortium

Neolys Diagnostics is a biotechnology company specialised in precision medicine for radiation oncology. Neolys develops innovative medical tests combining DNA repair biomarkers with radiotherapy treatment parameters to anticipate and reduce treatment-related side effects, optimise therapeutic efficacy, and support more personalised radiotherapy strategies.

Within the TETRIS project, Neolys contributes its expertise in functional radiosensitivity testing and oncology innovation under the leadership of Sandrine Pereira, Scientific Director of Neolys Diagnostics.

Neolys leads:
🧪 WP8 – Cellular Sensitivity Testing in the TETRIS Prospective Cohort, focused on assessing cellular radiosensitivity and integrating functional biomarkers with genetic information, including Polygenic Risk Scores (PRS) derived from SNP analysis, to enable multidimensional patient risk profiling.

🔗 Learn more about Neolys Diagnostics and its role in the TETRIS project on our website 🌐 urlr.me/wCdGxf

...

2 0
📢 Thank you for joining the first TETRIS Educational Webinar!

A big thank you to everyone who participated in the first webinar of the TETRIS Educational Webinar Series, delivered by Eva Onjukka and Filippo Schiavo, from Karolinska University Hospital, and moderated by Tiziana Rancati, Project Investigator of the TETRIS project, from Fondazione IRCCS Istituto Nazionale dei Tumori. 

Key takeaways from the webinar:
·  radiation-induced side effects in patients treated with radiotherapy and on how these outcomes are measured using clinician- and patient-reported scales. 
·  importance of evaluating model performance, with a strong emphasis on calibration, crucial for communicating absolute risk to patients, alongside discrimination metrics

🔁 Missed the webinar or would like to watch it again? 
Read the full news on our website here urlr.me/t8nvBQ and access the full recording on TETRIS YouTube channel.

We look forward to welcoming you to the next TETRIS Educational Webinars!

@Karolinska Universitetssjukhuset @karolinskaunivsjukh @istituto_tumori

...

2 0
📢 TETRIS Educational Series. Second Webinar

Following the great participation from our first TETRIS educational webinar, we are pleased to announce that we are ready for the second event of the series.

🗓 Friday, 27 February
⏰ 13:00–14:00 CET

In this second webinar, Claudio Fiorino and Martina Mori from Università Vita-Salute San Raffaele UniSR, will present “Methods for assessing imaging biomarkers in breast cancer radiotherapy within the TETRIS project”
This session will focus on methodological approaches for evaluating imaging biomarkers in breast cancer radiotherapy, highlighting their role within the TETRIS project to support personalised risk assessment and safer treatment pathways. 

👉 To join click here: the session urlr.me/QRzacM.

We look forward to welcoming you to the second appointment of the TETRIS Educational Series. @unisr @Università Vita-Salute San Raffaele @ospedalesanraffaele @IRCCS Ospedale San Raffaele 

Image “Designed by Freepik”, www.freepik.com.

...

1 0